Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1Global Biodefense StaffApril 26, 2026
Medical Countermeasures UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next PandemicGlobal Biodefense StaffApril 23, 2026
Pharma Leaders Issue Joint Declaration on Combating Antimicrobial Resistance Antimicrobial Resistance January 21, 2016 …
Profectus BioSciences Initiates Ebola Vaccine Phase 1 Trial Medical Countermeasures January 20, 2016 …
NIAID Awards 5M for Non-Traditional Bacterial Infection Treatments Antimicrobial Resistance January 12, 2016 …
JP Morgan Conference Turns San Francisco into Biotech Convergence Zone Biodetection December 28, 2015 …
Profectus Awarded Grant to Develop Select Agent Countermeasures Contracts + Grants December 9, 2015 …
